The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

10476–10500 of 11860

  • SevereFDA (Drugs)·D-414-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Combo Eye Gel Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Combo Eye Gel because sterility cannot be assured after another product was found non-sterile in the same environment.

    Product
    Combo Eye Gel, HF COMBO EYE GEL* (cyclopentolate 2%, tropicamide 1%, diclofenac sodium 0.1%, ciprofloxacin 0.3%, phenylephrine 10%, lidocaine jelly 2%), Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-519-2014·2014-01-22

    Finasteride Tablets Recalled for Potential Mislabeling as Other Medications

    Aidapak Services is recalling Finasteride 5 mg tablets that may be mislabeled as Digoxin or Phytonadione. The error poses a risk of incorrect medication administration.

    Product
    FINASTERIDE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714052201
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-644-2014·2014-01-22

    Aidapak Recalls Nifedipine Capsules Due to Potential Labeling Error

    Aidapak Services is recalling Nifedipine 10 mg capsules because they may be mislabeled as Nitrofurantoin 100 mg. The repacked drugs were distributed in four western states.

    Product
    NIFEdipine Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 59762100401
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-608-2014·2014-01-22

    FDA Recalls FIDAXOMICIN Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling FIDAXOMICIN 200 mg tablets that may be mislabeled as BENAZEPRIL HCL 40 mg. The error affects repacked drugs distributed in four western states.

    Product
    FIDAXOMICIN Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 52015008001
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-457-2014·2014-01-22

    Calcium Chloride Injection Recalled Due to Sterility Assurance Concerns

    Specialty Medicine Compounding Pharmacy is recalling Calcium Chloride PF 500 mg/mL prefilled syringes because sterility cannot be assured after a related product was found non-sterile.

    Product
    Calcium Chloride* PF 500 mg/mL pref syringe, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-449-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Testos Cypionate Injectable Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Testos Cypionate injectable products because sterility cannot be assured after a related product was found non-sterile.

    Product
    TESTOS CYPIONATE* IN OIL 100 mg/mL INJECTABLE, TESTOS CYPIONATE* IN OIL 200 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-434-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Naltrexone MDV Injectable

    Specialty Medicine Compounding Pharmacy is recalling Naltrexone MDV 1mg/mL injectable because sterility cannot be assured due to shared compounding practices with a non-sterile product.

    Product
    NALTREXONE* MDV 1MG/ML INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-430-2014·2014-01-22

    Methocarbamol Injectable Recalled Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Methocarbamol 100 mg/mL injectable because sterility cannot be assured after a related product was found non-sterile.

    Product
    METHOCARBAMOL (REPACK) 100 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-596-2014·2014-01-22

    Rivaroxaban Tablets Recalled for Potential Venlafaxine Labeling Error

    Aidapak Services is recalling Rivaroxaban 20 mg tablets that may be mislabeled as Venlafaxine HCL 100 mg due to a label mixup.

    Product
    RIVAROXABAN Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50458057930
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-673-2014·2014-01-22

    Aidapak Recalls OXcarbazepine Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling OXcarbazepine 150 mg tablets because they may be mislabeled as traZODone HCl 50 mg.

    Product
    OXcarbazepine Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756018388
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-602-2014·2014-01-22

    Warfarin Sodium Tablets Recalled Due to Potential Label Mixup

    Aidapak Services is recalling Warfarin Sodium 0.5 mg tablets because they may be mislabeled as Sodium Chloride 1 mg tablets.

    Product
    WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-675-2014·2014-01-22

    Letrozole Tablets Recalled for Potential Mislabeling as Metoprolol Tartrate

    Aidapak Services, LLC is recalling Letrozole 2.5 mg tablets that may be mislabeled as Metoprolol Tartrate 50 mg. The error could lead to patients receiving the wrong medication.

    Product
    LETROZOLE Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756051183
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-455-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls VIGAMOX Syringes Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling 204 doses of VIGAMOX (moxifloxacin) syringes because sterility cannot be assured after another product was found non-sterile.

    Product
    VIGAMOX (moxifloxacin)* IN BSS (0.15 %) 0.75 mg/0.5 mL PREF SYRINGE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-600-2014·2014-01-22

    Aidapak Recalls Clomipramine Capsules Due to Potential Labeling Errors

    Aidapak Services is recalling Clomipramine HCl capsules because they may be mislabeled as other prescription medications.

    Product
    clomiPRAMINE HCl Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51672401205
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-494-2014·2014-01-22

    FDA Recalls Melatonin Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling 1 mg melatonin tablets that may be mislabeled as quetiapine fumarate or docusate sodium.

    Product
    MELATONIN, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 04746900466
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-447-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Hydroxyprogesterone Injectable Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Hydroxyprogesterone 17alpha-PF 250 mg/mL injectable because sterility cannot be assured after a related product was found non-sterile.

    Product
    HYDROXYPROGEST*-17ALPHA -PF 250 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-697-2014·2014-01-22

    Aidapak Recalls Lubiprostone Capsules Due to Potential Labeling Errors

    Aidapak Services is recalling Lubiprostone capsules because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    LUBIPROSTONE Capsule, 24 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764024060
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-714-2014·2014-01-22

    Colesevelam HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services is recalling Colesevelam HCL tablets that may be mislabeled as lamoTRIgine due to a labeling error.

    Product
    COLESEVELAM HCL Tablet, 625 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65597070118
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-433-2014·2014-01-22

    Naloxone Injectable Recalled Due to Lack of Assurance of Sterility

    Specialty Medicine Compounding Pharmacy is recalling Naloxone HCL 0.4mg/mL injectable because sterility cannot be assured after a related product was found to be non-sterile.

    Product
    NALOXONE HCL* 0.4MG/ML INJECTABLE, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-689-2014·2014-01-22

    Aidapak Recalls Mislabeled Pantoprazole Sodium Tablets

    Aidapak Services, LLC is recalling 20 mg Pantoprazole Sodium tablets that may be mislabeled as Fosinopril Sodium. The error involves a label mixup on repacked drugs.

    Product
    PANTOPRAZOLE SODIUM DR Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64679043304
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-464-2014·2014-01-22

    Aidapak Recalls Calcium Carbonate Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 10,819 tablets of Calcium Carbonate +D3 because they may be mislabeled as Digoxin or Amantadine HCl.

    Product
    CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904323392.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-653-2014·2014-01-22

    Aidapak Recalls Vitamin B Complex Tablets Due to Labeling Mixup

    Aidapak Services, LLC is recalling Vitamin B Complex with C/Folic Acid tablets because they may be mislabeled as other prescription or over-the-counter medications.

    Product
    VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258016001
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-443-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Quad Mix Injectable Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Quad Mix and Super Quad Mix injectables because sterility cannot be assured after a related product was found non-sterile.

    Product
    QUAD MIX* 0.05 mg/25 mg/2 mg/25 mcg/mL INJECTABLE, QUAD MIX* 0.1 mg/30 mg/2 mg/20 mcg INJECTABLE, QUAD MIX* 0.1 mg/30 mg/2 mg/50 mcg INJECTABLE, QUAD MIX* 0.1 mg/9 mg/1 mg/10 mcg/mL INJECTABLE, SUPER QUAD MIX* 0.1 mg/30 mg/2 mg/20 mcg INJECTABLE, (pavaperine HCl, phentolamine, pr
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-419-2014·2014-01-22

    Specialty Medicine Compounding Pharmacy Recalls Epinephrine Due to Sterility Concerns

    Specialty Medicine Compounding Pharmacy is recalling Epinephrine products because sterility cannot be assured after a related product was found non-sterile.

    Product
    EPINEPHRINE PF SF* (0.3 mL); (1 mL), (0.5 mL IN 3 mL SYRINGE) 1:1000 OPHTH SOL, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
    Category
    Drug
    Distribution
    1 state
  • HighFDA (Drugs)·D-645-2014·2014-01-22

    Aidapak Recalls Mirtazapine Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Mirtazapine 7.5 mg tablets because they may be mislabeled as other prescription medications.

    Product
    MIRTAZAPINE Tablet, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 59762141503
    Category
    Drug
    Distribution
    4 states